"Item","Total","Cards","PCPs","Nephs","Endos","Lipids","Physician","NP/PA","Higher","Lower","Tier 1","Tier 2","Tier 3","Tier 4","Segment A","Segment B","Segment C","Segment D","Priority Account","Non-Priority Account"
"Leqvio (inclisiran)","39% (70)","43% (52)","28% (15)","0% (0)","60% (3)","0% (0)","40% (60)","17% (2)","41% (37)","37% (33)","33% (14)","39% (32)","48% (22)","25% (2)","36% (20)","43% (16)","31% (11)","45% (22)","40% (53)","36% (17)"
"Praluent (alirocumab)","37% (67)","38% (46)","36% (19)","0% (0)","40% (2)","0% (0)","37% (56)","25% (3)","37% (34)","37% (33)","30% (13)","42% (35)","39% (18)","13% (1)","34% (19)","46% (17)","36% (13)","35% (17)","41% (54)","28% (13)"
"Repatha (evolocumab)","37% (66)","40% (48)","30% (16)","0% (0)","40% (2)","0% (0)","37% (55)","25% (3)","36% (33)","37% (33)","33% (14)","37% (31)","43% (20)","13% (1)","36% (20)","46% (17)","28% (10)","37% (18)","41% (54)","26% (12)"
"Nexletol (bempedoic acid) or Nexlizet (bempedoic acid and ezetimibe)","40% (72)","44% (53)","36% (19)","0% (0)","0% (0)","0% (0)","41% (62)","25% (3)","41% (37)","39% (35)","33% (14)","43% (36)","37% (17)","63% (5)","39% (22)","41% (15)","39% (14)","41% (20)","41% (55)","36% (17)"
